1. HBW Insight
  2. >>Wellness
  4. >>Regulation

FDA's CBD Docket Comments: Harm Reduction To Churches, 'More Humane' Medication To 'Source Of Confusion'

 
• By Malcolm Spicer

Consumers' submissions, many with anonymous attribution, account for most of the 776 comments FDA has received to its "Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds" docket. Few provide data or other information FDA asks for and some organizations' comments align with consumers by focusing on sentiment and appreciation.

US map-cannibis-plants

The US Food and Drug Administration seeks scientific input on whether to allow using hemp and cannabidiol in dietary supplements at a public hearing on May 31, but a large majority of comments already submitted offer little more than personal anecdotes about the ingredients' health benefits.

Consumers' submissions, many with anonymous attribution, account for most of the 776 comments the FDA already has received to its...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

CHPA Survey Shows Consumer Trust In Supplements Strong, Not So Much In Regulation

 
• By Malcolm Spicer

Results of survey found a majority of representative sample of US voters nationwide agree “current regulations should be updated and strengthened to protect consumers,” CHPA says.